Medical Care Technologies Inc. (OTC PINK:MDCE) Expands Development of Consumer-Grade AI Pre-Health Screening Tools Focused on Early Detection

Rhea-AI Summary

Medical Care Technologies (OTC PINK: MDCE) is expanding development of consumer-grade AI pre-health screening mobile apps to detect early warning signs of serious conditions and prompt timely medical follow-up.

The initiative builds on MDCE's prior work in early melanoma detection and broadens its AI models to assess dermatology (skin lesions), ocular health markers, and lifestyle and health-behavior risk trends. The tools are described as deep-learning models trained on medical datasets and designed to provide consumer-friendly preliminary screening insights via mobile devices.

Management emphasizes early detection and aims to make proactive screening technology widely accessible from smartphones.

MESA, ARIZONA / ACCESS Newswire / December 2, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that the company is expanding its development efforts into a new generation of consumer-grade AI pre-health screening mobile applications designed to help identify early warning signs of serious health conditions and encourage timely medical intervention.

This initiative builds upon MDCE's previously announced breakthrough in early melanoma detection. The company is now leveraging that technological foundation to broaden its AI capabilities across multiple high-risk categories, creating accessible tools that support individuals before symptoms become critical.

Advancing At-Home Early Detection

MDCE's next wave of consumer applications integrates deep-learning models trained on medical datasets to assess early-risk indicators related to:

• Dermatology and skin-lesion irregularities

• Ocular health markers

• Lifestyle and health-behavior risk trends

These tools are being engineered to provide consumer-friendly, preliminary screening insights that can help users recognize potential issues earlier and seek professional evaluation when appropriate.

"Early detection saves lives, and our goal is to make that proactive technology available to everyone," said Marshall Perkins III, CEO of Medical Care Technologies Inc. "We are fully committed to developing consumer-grade AI tools that deliver early health insights right from a mobile device."

---

About Medical Care Technologies Inc. (MDCE)

Medical Care Technologies Inc. (OTC PINK: MDCE) is committed to developing AI-driven technologies that advance preventive healthcare and consumer health intelligence. The company focuses on artificial intelligence applications spanning dermatology, ocular health, neurological tracking, wellness analytics, diet/nutrition and early-risk detection tools.

Websites: www.medicalcaretechnologies.com | www.mdcestock.com

---

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual results to differ materially from those described. The company undertakes no obligation to update or revise forward-looking statements except as required by law.

---

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)

View the original press release on ACCESS Newswire

FAQ

What did Medical Care Technologies (MDCE) announce on December 2, 2025 about AI screening?

MDCE announced expansion of development for consumer-grade AI pre-health screening mobile apps to identify early warning signs across multiple high-risk categories.

Which health areas will MDCE's new AI mobile apps assess for early risk?

The apps are being developed to assess dermatology (skin-lesion irregularities), ocular health markers, and lifestyle and health-behavior risk trends.

How does MDCE plan to build on its prior technology for these apps?

MDCE is leveraging its previously announced breakthrough in early melanoma detection as a foundation to broaden AI capabilities across other risk categories.

Will MDCE's AI apps provide medical diagnoses or preliminary screening insights?

The company says the tools are engineered to provide consumer-friendly preliminary screening insights to help users recognize potential issues and seek professional evaluation when appropriate.

What technology underpins MDCE's consumer screening tools?

MDCE describes integrating deep-learning models trained on medical datasets into mobile applications to assess early-risk indicators.

What is MDCE's stated goal for these AI pre-health tools?

MDCE's stated goal is to make proactive early-detection technology available to everyone via mobile devices to help prompt timely medical intervention.